Helicobacter pylori (H. pylori) is one of the most common chronic bacterial infections in the world, present in an estimated 30–40% of people in the United States. In many people it causes no symptoms at all. In others, over years, it contributes to inflammation of the stomach lining, peptic ulcers, and — in a small minority of cases — more serious conditions. The standard, evidence-based medical treatment for a confirmed H. pylori infection is a course of antibiotics prescribed by a doctor, and nothing on this page is a substitute for that.
What has interested researchers is whether haritaki (Terminalia chebula), long used in Ayurveda for digestive complaints, shows any activity against this particular bacterium in the laboratory. The short answer is that early research is genuinely intriguing — but it is preliminary, and it is important to be clear about what it does and does not show.
What the research actually shows
A study conducted at the University of Tehran tested extracts of Terminalia chebula against H. pylori and reported significant antibacterial activity in vitro — that is, in the controlled environment of a laboratory dish. A separate comparison of four Ayurvedic herbs found Terminalia chebula to be the strongest antioxidant of the group.
These are laboratory findings. An extract that suppresses a bacterium in a petri dish has cleared a very different — and much lower — bar than a treatment shown to eradicate an infection in the human stomach, which is a far more complex environment involving stomach acid, the mucosal lining, and the body’s own immune response. To date, haritaki has not been established in clinical trials as a treatment for H. pylori infection in people. It is a promising area for further study, not a proven therapy.
In Ayurvedic tradition, Terminalia chebula is used broadly for digestive balance, and its principal constituents — chebulagic acid, chebulinic acid, and corilagin — have been studied for antioxidant and antimicrobial properties. That traditional and preliminary-scientific picture is worth knowing. It is not the same thing as a cure.
Why H. pylori matters
H. pylori is now understood to be the cause of the majority of peptic ulcers — more than 90% of duodenal ulcers and up to 80% of gastric ulcers — overturning the older belief that ulcers were caused mainly by stress and diet. Because a long-standing, untreated infection can have serious consequences, testing and treatment are a matter for a healthcare provider, not self-management with supplements.
If you suspect you have an H. pylori infection — persistent stomach pain, bloating, nausea, or a diagnosed ulcer — see a doctor. Diagnosis is straightforward (breath, stool, or endoscopic tests) and effective treatment exists. If you are interested in haritaki as part of a general approach to digestive wellness, that is a reasonable conversation to have with a qualified practitioner alongside — not instead of — appropriate medical care.
Learn more about haritaki
For the traditional and scientific background on this herb, see our complete guide to haritaki (Terminalia chebula) and the main benefits page.
These statements have not been evaluated by the Food and Drug Administration. Haritaki is a traditional herb and food, not a drug, and is not intended to diagnose, treat, cure, or prevent any disease — including H. pylori infection or peptic ulcers. The research described here is preliminary and largely laboratory-based. Always consult a qualified healthcare provider for the diagnosis and treatment of any infection or medical condition.